Related references
Note: Only part of the references are listed.CRAVAT: cancer-related analysis of variants toolkit
Christopher Douville et al.
BIOINFORMATICS (2013)
Identifying Mendelian disease genes with the Variant Effect Scoring Tool
Hannah Carter et al.
BMC GENOMICS (2013)
Poor survival with wild-type TP53 ovarian cancer?
Kwong-Kwok Wong et al.
GYNECOLOGIC ONCOLOGY (2013)
Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models
Hashem A. Shihab et al.
HUMAN MUTATION (2013)
Clonal competition with alternating dominance in multiple myeloma
Jonathan J. Keats et al.
BLOOD (2012)
Phenotype-Optimized Sequence Ensembles Substantially Improve Prediction of Disease-Causing Mutation in Cystic Fibrosis
David L. Masica et al.
HUMAN MUTATION (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2011)
Prediction of Missense Mutation Functionality Depends on Both the Algorithm and Sequence Alignment Employed
Stephanie Hicks et al.
HUMAN MUTATION (2011)
Performance of Mutation Pathogenicity Prediction Methods on Missense Variants
Janita Thusberg et al.
HUMAN MUTATION (2011)
Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial
David Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Thorsten Zenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Ana I. Robles et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
Hannah Carter et al.
CANCER RESEARCH (2009)
The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas
Estrid V. S. Hogdall et al.
APMIS (2008)
Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival
Frank Bartel et al.
CLINICAL CANCER RESEARCH (2008)
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study
Kathleen M. Darcy et al.
GYNECOLOGIC ONCOLOGY (2008)
In Silico Analysis of Missense Substitutions Using Sequence-Alignment Based Methods
Sean V. Tavtigian et al.
HUMAN MUTATION (2008)
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene
C. Bonnet et al.
JOURNAL OF MEDICAL GENETICS (2008)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interpreting missense variants:: Comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR)
Philip A. Chan et al.
HUMAN MUTATION (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig et al.
NATURE REVIEWS CANCER (2005)
Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations
T Soussi et al.
HUMAN MUTATION (2005)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
E Steels et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Share Paper
